We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRUS:NASDAQCirrus Logic, Inc. Analysis

Data as of 2026-05-31 - not real-time

$169.95

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Cirrus Logic posted a record FY‑2026 revenue of $2.0 B, up 5% YoY, and delivered a non‑GAAP EPS of $9.26, eclipsing forecasts with an 11.4% EPS surprise. The stock trades at $169.95, comfortably above its 20‑day SMA (≈$168) and 50‑day SMA (≈$160), while the MACD remains bullish and the RSI sits near 54, indicating neutral momentum. With support around $156.7 and resistance near $180.4, the DCF‑derived fair value of $183.8 suggests roughly a 6‑7% upside, reinforced by an “Extreme Greed” sentiment reading and a beta of ~1.07 despite a 38% 30‑day volatility.
From a valuation perspective, CRUS appears modestly undervalued versus the semiconductor industry’s average PE of ~42 and its forward PE of 18.1, while boasting a solid ROE of ~20% and ample cash balances. The company carries low debt, no dividend, and strong operating margins, yet faces typical semiconductor sector cyclicality, exposure to Chinese manufacturing, and a decreasing volume trend that temper the upside. Overall, the fundamentals and technicals support a positive short‑ to medium‑term outlook, with caution advised for long‑term investors due to sector and geographic risks.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical setup (price above SMA, bullish MACD)
  • Recent earnings beat and EPS surprise
  • Upside potential toward DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Attractive valuation relative to industry peers
  • Strong cash generation and low leverage
  • Growth opportunities in audio, automotive and AR/VR markets

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Solid ROE and operating margins
  • Cyclical nature of semiconductor sector
  • Exposure to China‑related geopolitical risk

Key Metrics & Analysis

Financial Health

Revenue Growth5.70%
Profit Margin20.75%
P/E Ratio21.6
ROE20.33%
ROA11.95%
Debt/Equity6.30
P/B Ratio4.0
Op. Cash Flow$650.6M
Free Cash Flow$505.7M
Industry P/E41.9

Technical Analysis

TrendBullish
RSI54.2
Support$156.67
Resistance$180.42
MA 20$168.09
MA 50$160.37
MA 200$134.16
MACDBullish
VolumeDecreasing
Fear & Greed Index94.07

Valuation

Fair Value$183.85
Target Price$181.40
Upside/Downside6.74%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.07
Volatility38.00%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.